Fulgent Genetics agrees to buy StrataDx and assets from Bako Diagnostics for $55.5 million. Learn how this cash deal expands ...
Affidea acquires a majority stake in LabPoint from Lindenhofgruppe, strengthening its diagnostics and laboratory medicine ...
CyPath® Lung addresses urgent unmet need in projected $10.4 billion lung cancer diagnostic market by 2034Precision Pathology Laboratory Services meets gold standard for excellence across all ...
El Monte-based lab testing and pharmaceutical company Fulgent Genetics Inc. last month simultaneously announced a pair of ...
6don MSN
Seattle’s Alpenglow moves 3D microscope tech from lab to clinic to help modernize cancer diagnostics
Alpenglow Biosciences announced a partnership with PathNet to help commercialize use of the startup's 3D microscope ...
The new pathology laboratory of the Georgetown Public Hospital Corporation (GPHC) was on Wednesday awarded an ISO [International Organization for Standardization] 15189 Plus Accreditation which a GPHC ...
Karen Frank, chief of the Department of Laboratory Medicine at the National Institutes of Health Clinical Center, has been ...
Backers of the ASX-listed pathology player are pushing for a break-up of the company as new boss Jim Newcombe reviews the ...
The implementation of Sectra's digital pathology module at Kameda Medical Center follows a contract signed in the second quarter of Sectra's 2025/2026 fiscal year. The contract was sold by Sectra's ...
Construction work of Central Main Veterinary Laboratory project at Old Airport area progressing at a good pace ...
Proposed acquisition will add new anatomic pathology services, proprietary PCR tests and a national client base EL MONTE, Calif., December 22, 2025--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback